Key Business Development Executive Placement Expands Occam's Public Biotech Practice
In September 2024, Occam Global placed Ryan Pinto, PhD as Vice President Business Development (VP BD) of Schrödinger (NASDAQ: SDGR), an industry leader in the Life Sciences computational tool space.
Pinto comes to Schrödinger from Function Oncology and previously Foundation Medicine where he held roles of increasing responsibility in corporate and business development. Ryan's combination of scientific training and track record of creative deal making at the intersection of AI/ML, tools/services, and drug discovery/development are uniquely suited to Schrödinger’s needs at this juncture.
Ryan holds a PhD in molecular biology in oncology from the University of Toronto and an MBA from London Business School.
Occam Global is a biotech executive search, recruiting, and leadership advisory firm with specialties across technological fields, including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build biotech executive leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.